title: Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections.
authors.forename: Ngan
authors.initials: N
authors.lastname: Lam
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Weir
authors.forename: David N
authors.initials: DN
authors.lastname: Juurlink
authors.forename: Nadia
authors.initials: N
authors.lastname: Gunraj
authors.forename: Tara
authors.initials: T
authors.lastname: Gomes
authors.forename: Muhammad
authors.initials: M
authors.lastname: Mamdani
authors.forename: Daniel G
authors.initials: DG
authors.lastname: Hackam
authors.forename: Arsh K
authors.initials: AK
authors.lastname: Jain
authors.forename: Amit X
authors.initials: AX
authors.lastname: Garg
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000453:epidemiology / Q000628:therapy; D015994:Incidence; D009864:Ontario / Q000453:epidemiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination